Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Return on Sales (2016 - 2017)

Historic Return on Sales for Soleno Therapeutics (SLNO) over the last 6 years, with Q1 2018 value amounting to 2751.0%.

  • Soleno Therapeutics' Return on Sales fell 27478200.0% to 2751.0% in Q1 2018 from the same period last year, while for Mar 2018 it was 2751.0%, marking a year-over-year decrease of 27462800.0%. This contributed to the annual value of 761.26% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2018, Soleno Therapeutics' Return on Sales is 2751.0%, which was down 27478200.0% from 13.51% recorded in Q4 2017.
  • In the past 5 years, Soleno Therapeutics' Return on Sales registered a high of 2.95% during Q2 2014, and its lowest value of 2751.0% during Q1 2018.
  • For the 5-year period, Soleno Therapeutics' Return on Sales averaged around 261.0%, with its median value being 9.54% (2016).
  • As far as peak fluctuations go, Soleno Therapeutics' Return on Sales soared by 1007800bps in 2016, and later plummeted by -27478200bps in 2018.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Return on Sales stood at 1.8% in 2014, then tumbled by -909bps to 14.52% in 2015, then surged by 71bps to 4.2% in 2016, then plummeted by -222bps to 13.51% in 2017, then plummeted by -20266bps to 2751.0% in 2018.
  • Its last three reported values are 2751.0% in Q1 2018, 13.51% for Q4 2017, and 7.71% during Q3 2017.